Abstract
Dendrimers are hyper branched macro molecules with well-defined structure and high degree of functionality on the surface. The dendrimer architecture allows control over properties such as shape, size, density, polarity, reactivity, solubility etc. These special features can be exploited to design molecules having desired properties used for biomedical applications. Recent advancements in correlation between structure and biodegradability and in vivo performance are opening up new avenues for these molecules; particularly, in biological applications like drug delivery. The unique structure of dendrimers provides enough attachment sites for drugs. Further, it is possible to tune the molecules in such a way so that the drug molecules are encapsulated outside the target area and are released only in the local environment of targets. This review presents some general aspects of dendrimers and how their properties are exploited for drug delivery applications.
Keywords: Biomedical applications, conjugation, dendrimer, pharmaceutical, drug delivery systems, encapsulation, prodrug.
Mini-Reviews in Medicinal Chemistry
Title:Dendrimers: General Aspects, Applications and Structural Exploitations as Prodrug/Drug-delivery Vehicles in Current Medicine
Volume: 18 Issue: 5
Author(s): Merina Mariyam, Kajal Ghosal*, Sabu Thomas, Nandakumar Kalarikkal and Mahima S. Latha*
Affiliation:
- Centre for Nanoscience and Nanotechnology, Mahatma Gandhi University, Priyadarshini Hills, Kottayam, Kerala 686560,India
- Centre for Nanoscience and Nanotechnology, Mahatma Gandhi University, Priyadarshini Hills, Kottayam, Kerala 686560,India
Keywords: Biomedical applications, conjugation, dendrimer, pharmaceutical, drug delivery systems, encapsulation, prodrug.
Abstract: Dendrimers are hyper branched macro molecules with well-defined structure and high degree of functionality on the surface. The dendrimer architecture allows control over properties such as shape, size, density, polarity, reactivity, solubility etc. These special features can be exploited to design molecules having desired properties used for biomedical applications. Recent advancements in correlation between structure and biodegradability and in vivo performance are opening up new avenues for these molecules; particularly, in biological applications like drug delivery. The unique structure of dendrimers provides enough attachment sites for drugs. Further, it is possible to tune the molecules in such a way so that the drug molecules are encapsulated outside the target area and are released only in the local environment of targets. This review presents some general aspects of dendrimers and how their properties are exploited for drug delivery applications.
Export Options
About this article
Cite this article as:
Mariyam Merina , Ghosal Kajal *, Thomas Sabu , Kalarikkal Nandakumar and Latha S. Mahima *, Dendrimers: General Aspects, Applications and Structural Exploitations as Prodrug/Drug-delivery Vehicles in Current Medicine, Mini-Reviews in Medicinal Chemistry 2018; 18 (5) . https://dx.doi.org/10.2174/1389557517666170512095151
DOI https://dx.doi.org/10.2174/1389557517666170512095151 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vascular Risk Factors and Lesions of Vascular Nature in Magnetic Resonance as Predictors of Progression to Dementia in Patients with Mild Cognitive Impairment
Current Alzheimer Research Exosomes: Structure, Biogenesis, Types and Application in Diagnosis and Gene and Drug Delivery
Current Gene Therapy Therapeutic Targets for Heart Failure: Beyond Beta-Adrenergic and Renin-Angiotensin System Blockade
Recent Patents on Cardiovascular Drug Discovery Diabetes and Antioxidants: Myth or Reality?
Current Vascular Pharmacology The Crosstalk Between Insulin and Renin-Angiotensin-Aldosterone Signaling Systems and its Effect on Glucose Metabolism and Diabetes Prevention
Current Vascular Pharmacology Biomarkers in Post-stroke Depression
Current Neurovascular Research Identification of Genes for a Complex Trait: Examples from Hypertension
Current Pharmaceutical Biotechnology Fish Oil Supplementation: A Matter of DHA Enzymatic/Non-Enzymatic Oxidation Balance?
Current Nutrition & Food Science Targeting the PI3K/Akt/mTOR Axis by Apigenin for Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry University of Kentucky Sanders-Brown Healthy Brain Aging Volunteers: Donor Characteristics, Procedures and Neuropathology
Current Alzheimer Research Critical Roles of Insulin-Induced Senescence in Diabetic Vasculopathy
Vascular Disease Prevention (Discontinued) Salusins in Hypertension and Related Cardiovascular Diseases
Current Drug Metabolism Lyn Regulates Cytotoxicity in Respiratory Epithelial Cells Challenged by Cigarette Smoke Extracts
Current Molecular Medicine Healthspan and Longevity in Mammals: A Family Game for Cellular Organelles?
Current Pharmaceutical Design A Therapeutic Target of Cerebral Hemorrhagic Stroke: Matrix Metalloproteinase- 9
Current Drug Targets Mechanisms and Characteristics of Sulfonylureas and Glinides
Current Topics in Medicinal Chemistry Premature Ovarian Insufficiency and Long-Term Health Consequences
Current Vascular Pharmacology ATP-Binding Cassette Transporters A1 and G1, HDL Metabolism, Cholesterol Efflux, and Inflammation: Important Targets for the Treatment of Atherosclerosis
Current Drug Targets Editorial [Hot topic: The Inflammation Paradigm in Cardiovascular Disease (Guest Editor: Guha Krishnaswamy)]
Cardiovascular & Hematological Disorders-Drug Targets Perioperative B-blockers in Non-cardiac Surgery: Actual Situation
Current Pharmaceutical Design